In vitro suppression of FADD reduced the proliferation of lung cancer cells and altered expression of apoptosis (BAX/BCL-2) and pyroptosis (Caspase-1/NLRP3) markers, suggesting that regulating pan-apoptotic markers may potentially become therapeutic targets for lung adenocarcinoma. The gene discussed is FADD; the disease is lung adenocarcinoma.